Source label information, not individualized medical advice. This record applies to the product and labeler shown below. Compare the exact formulation, strength and country with your package and the current source label.
Generic nameCALCIUM POLYCARBOPHIL
Labeler / manufacturerMedtech Products Inc.
RouteORAL
Drug classDrug class not supplied in source label
Product NDC63029-170
Label effective date2026-08-18
Official product label reference
Fibercon — Medtech Products Inc.
This page contains 15 source sections for CALCIUM POLYCARBOPHIL, oral route. Label set 59534afd-fe38-818a-e063-6394a90a21ea, version 1.
Label records can cover multiple strengths or package sizes. A label listing does not by itself establish FDA approval or current market availability. Check the source and application history for this specific product.
Uses described in the label
Uses relieves occasional constipation (irregularity) this product generally produces bowel movement in 12 to 72 hours
Purpose
Purpose Bulk-forming laxative
Dosage and administration — label text
Directions take each dose of this product with at least 8 ounces (a full glass) of water or other fluid. Taking this product without enough liquid may cause choking. See choking warning. FiberCon works with your body so continued use for one to three days is normally required to provide full benefit. Dosage may vary according to diet, exercise, previous laxative use or severity of constipation. adults and children 12 years of age and over: 2 caplets per dose. Do not take more than 8 caplets in 24 hours unless directed by a doctor. children under 12 years of age: ask a doctor
Warnings
Warnings Choking Taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product, seek immediate medical attention. Ask a doctor before use if you have abdominal pain, nausea, or vomiting a sudden change in bowel habits that lasts over a period of 2 weeks Ask a doctor or pharmacist before use if you are taking any other drug. Take this product 2 or more hours before or after other drugs. All laxatives may affect how other drugs work. When using this product do not use for more than 7 days unless directed by a doctor Stop use and ask a doctor if rectal bleeding occurs or if you fail to have a bowel movement after use of this or any other laxative. These could be signs of a serious condition. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Unclassified section
Drug Facts
Dist. by: Medtech Products Inc., Tarrytown, NY 10591, a Prestige Consumer Healthcare company 2026 fibercon.com WARNING: Risk of reproductive Harm - www.P65warnings.ca.gov
Active ingredient
Active ingredient (in each caplet) Calcium polycarbophil 625 mg equivalent to 500 mg polycarbophil
Ask a doctor before use
Ask a doctor before use if you have abdominal pain, nausea, or vomiting a sudden change in bowel habits that lasts over a period of 2 weeks
Ask a doctor or pharmacist
Ask a doctor or pharmacist before use if you are taking any other drug. Take this product 2 or more hours before or after other drugs. All laxatives may affect how other drugs work.
While using this medicine
When using this product do not use for more than 7 days unless directed by a doctor
When to stop use and seek help
Stop use and ask a doctor if rectal bleeding occurs or if you fail to have a bowel movement after use of this or any other laxative. These could be signs of a serious condition.
Child safety
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Storage and handling
Other information each caplet contains: 125 mg calcium protect contents from moisture store at 20-25°C (68-77°F)
The text is extracted from a US structured product label. Tables are represented as text where supplied; formatting and illustrations may be lost. A missing section does not mean a risk is absent. This reference has not been independently reviewed by a clinician and is not a live safety-alert service.